Prevalence of Asymptomatic Thrombosis in Multiple Myeloma
Malignant hemopathies, such as solid cancers, increase the risk of venous and arterial thromboembolic events. The incidence of symptomatic venous thromboembolic events is particularly high in myeloma, linked to the usual risk factors for venous thromboembolic disease, biological risk factors specific to myeloma, and especially to its treatments.
The prevalence of asymptomatic venous thromboembolic events and arterial events are not known to date and remain important data for planning a possible randomized study to determine the most suitable thromboprophylaxis in these patients.
研究概览
研究类型
阶段
- 不适用
联系人和位置
学习地点
-
-
Picardie
-
Amiens、Picardie、法国、80054
- CHU Amiens Picardie
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patient major age ≥18 years
- Patients with symptomatic myeloma meeting the definition of the International Myeloma Working Group, regardless of the therapeutic line, including patients in remission and untreated.
- Patient having given informed consent, signed.
- Patient benefiting from a social security scheme
Exclusion Criteria:
- Patients with non-symptomatic myeloma (stage I) or gammapathy of unknown significance (MGUS).
- Patient undergoing antithrombotic treatment for deep or superficial venous thrombosis and / or pulmonary embolism at the time of inclusion.
- Patients with occlusive arterial disease of the lower limbs known at the time of inclusion.
- Minors, protected adults and patients deprived of liberty or not affiliated to a social security scheme
- Pregnant woman
- Patient unable to express consent.
- Patient under guardianship or curatorship or patient deprived of public liberty
学习计划
研究是如何设计的？
设计细节
- 主要用途：其他
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
其他：Patient with multiple symptomatic myeloma
|
Echoing of the lower limbs and measuring the systolic pressure index
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Analysis of the occurrence of venous thromboembolic events via transverse Doppler echo
大体时间：1 day
|
1 day
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.